Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling.
Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, Lichter P, Kawauchi D, Gronych J.
Zuckermann M, et al. Among authors: lichter p.
Nat Commun. 2015 Jun 11;6:7391. doi: 10.1038/ncomms8391.
Nat Commun. 2015.
PMID: 26067104
Free PMC article.